CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Molrajas Yozshuk
Country: Trinidad & Tobago
Language: English (Spanish)
Genre: Love
Published (Last): 7 September 2009
Pages: 348
PDF File Size: 16.53 Mb
ePub File Size: 7.41 Mb
ISBN: 383-2-17244-469-8
Downloads: 10447
Price: Free* [*Free Regsitration Required]
Uploader: Dobei

CAT gastro-entérologie

Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Lanreotide in metastatic enteropancreatic neuroendocrine ictee. Hepatic metastases from neuroendocrine tumors with a “thin slice” pathological examination: Comment citer ce chapitre? Review and Position Statement. Updating the surgical management of peritoneal carcinomatosis in patients with neuroendocrine tumors.

Clin Cancer Res ; Phase III trial of chemotherapy using 5-fluorouracil and streptozotocin compared with interferon alpha for advanced carcinoid tumors: Frequency and characterization of gastro-entero-pancreatic neuroendocrine tumor patients with high-grade of uptake at somatostatin receptor scintigraphy. Updating the management of patients with rectal neuroendocrine tumors. Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours.


TNM staging of midgut and hindgut neuro endocrine tumors: Diagnosis and Prognostic Stratification. A phase II study of irinotecan with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.

Pour en savoir plus: Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract. International histological classification of tumours. Entre 1 et 2 cm: Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia. Streptozocin-doxorubicin, streptozocin-fluorouracil or chlorozotocin in the treatment of advanced islet-cell carcinoma.

Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.

Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their ca for therapy of metastatic neuroendocrine gastroenteropancreatic tumors–the International Lanreotide and Interferon Alfa Study Group.

Am J Surg Pathol. Computed tomography — an increasing source of radiation exposure.

CAT devant ictère néonatal by Farah Marraha on Prezi

O6-Methylguanine-DNA methyltransferase status in neuroendocrine tumours: Dig Liver Dis icteer Ki67 proliferation index, hepatic tumor load, and pretreatment tumor growth predict the antitumoral efficacy of lanreotide in patients with malignant digestive neuroendocrine tumors.


Examens morphologiques initiaux Am J Gastroenterol ; Everolimus quel que soit le volume tumoral niveau de la recommandation: J Interferon Cytokine Res ; New insights and treatment implications. Eur J Gastroenterol Hepatol.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control oftumor growth in patients with metastatic neuroendocrine midgut tumors: Everolimus for advanced pancreatic neuroendocrine devaht.

DTIC therapy in patients with malignant intraabdominal neuroendocrine tumors.

Copy of CAT devant une péritonite by Ismail Chafik on Prezi

The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors.

Jpn J Clin Oncol. Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours? N Engl J Med ; Comparison of efficacy and search for predictive factors guiding treatment choice.

Author: admin